Filter by: patients
Home > Community Treatment Reports and Side Effects > Didanosine (ddI) Treatment Report
What is Didanosine (ddI)?

Didanosine (2',3'-dideoxyinosine, ddI) is sold under the trade names Videx and Videx EC. It is a reverse transcriptase inhibitor, effective against HIV and used in combination with other antiretroviral drug therapy as part of highly active antiretroviral therapy (HAART). Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 22 3 Efficacy_major Efficacy_moderate
Other 1 0
dfd 1 0

See all 22 patients currently taking Didanosine (ddI)

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 0
None
 2

Commonly reported side effects, conditions, and hospitalizations associated with Didanosine (ddI)

Diarrhea 1
Cramps in stomach 1

Reported Dosages

  1 tbs. daily 200 mg 125 mg daily 150 mg daily 160 mg daily 250 mg daily 400 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 8 Number of Patients: 8  

Reported Stop Reasons

Why Patients Stopped Taking Didanosine (ddI) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 2   Side effects too severe: 40%
Did not seem to work 1   Did not seem to work: 20%
Other 1   Other: 20%
Course of treatment ended 1   Course of treatment ended: 20%

See all 5 patients who’ve stopped taking Didanosine (ddI)

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Didanosine (ddI)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Didanosine (ddI)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Didanosine (ddI)

Always
 3 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Didanosine (ddI)

Very
 0 0%
Somewhat
 1 33%
A little
 0 0%
Not at all
 2 67%

Cost

Paid out of pocket

Cost of Didanosine (ddI)

$200+
 0 0%
$100-199
 0 0%
$50-99
 1 50%
$25-49
 0 0%
< $25
 1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.